newsfilter
← Latest News
GlobeNewswire·

Harpoon Therapeutics Announces Up to $150 Million Private Placement

SOUTH SAN FRANCISCO, Calif., Oct. 23, 2023 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ:HARP) (the "Company"), a clinical-stage immunotherapy company developing novel T cell engagers, today announced that it